SubMagna HMW

10/19/2025

10/19/2025

🌍 From Texas to Tokyo - SubMagna® HMW is changing how the world compounds.

Any pharmacy, anywhere in the world, can use SubMagna® HMW - and frankly, everyone should. Every prescriber should DEMAND SubMagna® HMW be a part a compounded prescribed sublingual.

This innovative sublingual delivery base helps eliminate needles and improves sublingual delivery of Semaglutide, Sermorelin, NAD+ and so much more.

Innovation doesn’t have borders. Neither should better medicine.
👉 Learn more at www.SubMagna.com

Compounded medications are not reviewed by FDA for safety or efficacy.

Shark Tank Flamingo Charger Kingdom Investment Holdings Richie's Specialty Pharmacy PCCA RISE Institute for Compounding

10/12/2025

Where innovation meets impact. 💡❤️

At PCCA International 2025, SubMagna® HMW proudly stood alongside Smith Baggett, owner of Flamingo Charger (yes - the Shark Tank legend himself), and our friends at Bassagel, spotlighting how compounding innovation can fuel global philanthropy.

💥 Every share of this post on Facebook = $50 donated to the RISE Institute for Compounding, up to $50,000 total through October 15, 2025.

Together, we’re advancing patient care, empowering compounding pharmacies worldwide, and giving back to the profession that gives so much.

Let’s prove that innovation isn’t just about better medicine - it’s about better impact. 🌍

👉 Share this post.
👉 Tag your peers.
👉 Be part of the movement.



https://www.riseinstituteforcompounding.org/

09/27/2025

💡 GLP-1 medications are doing more than weight loss. They help with blood sugar, heart health, and may even reduce inflammation. Early research shows potential benefits in lupus and lupus nephritis - check out the article referenced!

For those wanting a needle-free option, some pharmacies offer compounded sublingual Semaglutide in SubMagna® HMW — simple and convenient under-the-tongue dosing.

👉 Learn more at www.subsema.com
| www.submagna.com

Compounded medications are not reviewed by FDA for safety or efficacy.



https://www.medpagetoday.com/rheumatology/lupus/117674?xid

It's getting harder to argue against these products as wonder drugs

09/23/2025

💡 Have Psoriasis?

GLP-1 medications like Semaglutide aren’t just about weight loss.

✨ New research shows they may also help with skin conditions such as psoriasis.

Pharmacies worldwide are compounding Semaglutide in SubMagna® HMW — a simple, needle-free sublingual option that makes access easier and more affordable.

👉 Learn more: www.SubSema.com and| www.SubMagna.com

⚠️ Compounded medications are not reviewed by the FDA for safety or efficacy.

Psoriasis is associated with cardiometabolic and psychiatric comorbidity. The anti-obesity and anti-diabetes glucagon-like peptide-1 receptor agonists (GLP

09/16/2025

Why might a compounded semaglutide dose look higher?

A weekly 7.2 mg subcutaneous dose (≈ 89% bioavailability) equates to ~6.4 mg absorbed. Assuming ~10% compounded sublingual absorption in SubMagna® HMW, an estimated 9.15 mg daily dose is needed to reach similar exposure. The latter is focused on estimates related to compounded drug products containing Semaglutide in SubMagna® HMW.

📌 Learn more: www.subsema.com and www.submagna.com

⚠️ Compounded medications are not FDA-reviewed for safety or efficacy. Sublingual absorption estimates are just that - estimates.

PCCA

Semaglutide 7·2 mg was superior to placebo and 2·4 mg for bodyweight reduction in adults with obesity, while retaining a favourable risk–benefit profile.

09/13/2025

SubMagna® HMW is a core / integral part of the referenced approach embraced by Richie's Specialty Pharmacy and pharmacies worldwide related to compounded sublingual delivery of drugs such as GLP-1s. Reach out to Richie's Specialty Pharmacy via richie@richiespharmacy.com. They're happy to share with you the approach they're doing and what they are seeing in patients.

PCCA

The FDA does not review any compounded medication for safety or efficacy. Richie’s Specialty Pharmacy® (“RSP”) is a registered trademark of Richie’s Pharmacy and Medical Supply, LLC. RSP serves patients solely within the state of Texas. No compounded medication is reviewed by FDA for safety...

09/08/2025

08/25/2025

🧪 Cannabis Delivery Innovation in Europe

As research into cannabis compounds and healthy aging gains momentum, European healthcare providers are investigating how SubMagna® HMW could be useful in compounded sublingual cannabinoid administration.

Why it matters: SubMagna® HMW's unique absorption profile could offer precision dosing, enhanced bioavailability, and non-invasive delivery for therapeutic cannabis applications.

📍 From pain management to neuroprotection, this could reshape how we think about formulation strategy and patient access.



Compounded medications are not reviewed by FDA for safety or efficacy.

Cannabis compounds are showing early promise for healthy aging, a new study has found. However, much more research is needed to learn how results might differ depending on the frequency of use and the individual. Researchers in the UK reviewed 18 different studies across 15 years of research (2008 t...

08/25/2025

💊 Sublingual Innovation Alert 💡

With Eli Lilly’s oral obesity pill (orforglipron) poised to enter the market, some compounding pharmacies are already exploring off-label adaptations. One emerging idea? Grinding the commercially available tablet and suspending it in SubMagna HMW - a high molecular weight mucoadhesive base - for sublingual delivery.

Pharmacies are evaluating:
✅ Particle size reduction protocols
✅ Stability and bioavailability in mucoadhesive matrices
✅ Patient-centric alternatives for those with GI intolerance or swallowing issues

This isn’t just formulation tinkering—it’s strategic positioning for access, adherence, and innovation in obesity care.

📣 Are you exploring sublingual GLP-1 strategies? Let’s connect and share insights.




Compounded medications are not reviewed for safety or efficacy.

PCCA

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.

08/11/2025

TRICARE for Life will stop covering GLP-1 weight-loss drugs like Wegovy® and Zepbound® on August 31, 2025.

For veterans and retirees affected by this change, compounded sublingual semaglutide in SubMagna® HMW could be a cost-effective alternative to discuss with your provider. Sublingual delivery avoids injections, supports absorption, and can be tailored to your needs.

📅 Talk to your healthcare provider before August 31 to explore your options.

Compounded medications are not reviewed by FDA for safety or efficacy.

tricare will no longer cover weight loss drugs such as zepbound, wegovy or other glp-1 medications.

08/08/2025

💥 Boost Energy. Support Recovery. Ignite Vitality. 💥

Compounded Sermorelin + NAD⁺ in SubMagna® HMW isn’t just another supplement - it’s a targeted performance and wellness solution. Sermorelin helps stimulate your body’s natural growth hormone production, supporting lean muscle, better sleep, and improved recovery. NAD⁺ fuels your cells with the coenzyme they need for optimal energy, mitochondrial health, and repair at the deepest level.

When combined in SubMagna® HMW, absorption is enhanced, delivering more of what your body needs right where it counts. The result? Faster recovery, sharper mental focus, better metabolism, and a healthier, stronger you — from the inside out.

⚡ Age Smarter. Perform Better. Live Stronger. ⚡

Compounded medications are not reviewed by FDA for safety and efficacy.



Kingdom Investment Holdings